Found 3,674 results
By Mike Larson On October 16, 201707:00 AM Eastern
Our company founder Martin D. Weiss is quite the world traveler. He and I have spent some time on the road together in Oakland, Las Vegas, Orlando, and elsewhere around the U.S. for investor...
By Jon D. Markman On October 9, 201702:00 PM Eastern
Every year, some of the smartest people on Wall Street get together to hobnob, raise money for charity and talk about their very best ideas.
This year, Dallas hosted the Great Investors Best...
By Mandeep Rai On September 13, 201707:00 AM Eastern
You’ve heard me talk about our Weiss Ratings Model plenty of times. But what is it really? How does it work? And most importantly, why should you care?
That’s a lot of questions, and I’ll start...
By Remi Lukosiunas On August 22, 201707:00 AM Eastern
Have you ever seen a bank tucked away in some shopping plaza, or just sitting on some lonely street corner? Then you looked at the name of it and thought to yourself: “What is this bank? I’ve...
By Mike Larson On August 14, 201707:00 AM Eastern
The North Korea crisis finally got the market’s attention last week. On Thursday alone, the Nasdaq Composite Index tanked more than 135 points, the CBOE VIX Index surged 42%, and “safe haven”...
By Mike Larson On June 9, 201707:00 AM Eastern
Okay, true confession time: I watch the bond market like a hawk. Nothing fascinates me more than interest rates.
That may not make me the most exciting cocktail party guest. But it has helped me...
By Remi Lukosiunas On May 2, 201707:00 AM Eastern
Stashing your cash in one place may not always be the best idea. It’s like picking your investments: You want to diversify your portfolio in case some of them underperform. But from the looks of...
By Mandeep Rai On April 26, 201707:50 AM Eastern
I want to start today’s column by showing you four charts – each of which illustrates the results from a different investment strategy. The red line in these charts shows the back-tested results...
By Mandeep Rai On March 8, 201707:00 AM Eastern
Small cap biotechnology stocks are some of my favorite investments. The innovations and cures you can find companies working on, and the rocketing of their stock prices once approvals are...
By Mike Larson On January 23, 201707:00 AM Eastern
Amid all the euphoria about Dow-almost-20,000, one group of stocks got left out of the party. Interest rate-sensitive sectors.
Just look at this table showing the recent performance of...